Related Experiment Videos
Opioid peptides in cancer
1Department of Medicinal Chemistry, Medical University of Lodz, Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Cancer Metastasis Reviews
|June 16, 2004
Summary
This review explores how opioid systems influence cancer growth. Researchers identified opioid ligands and receptors in human tumors, suggesting their role in regulating neoplasia.
Area of Science:
- Endocrinology
- Oncology
- Neuroscience
Background:
- Opioid and somatostatin systems are key mammalian inhibitory pathways regulating hormone secretion and cell proliferation.
- Opioids and their receptors are present in numerous human tumors and cancer cell lines.
- Research since the 1980s investigates the role of endogenous opioid systems in normal and abnormal tissue growth.
Purpose of the Study:
- To review recent findings on opioid ligands and receptors in human neoplasia.
- To examine the mechanisms of opioid peptide action in carcinoma.
- To discuss the involvement of opioids in tumor growth regulation.
Main Methods:
- Literature review of studies published since the early 1980s.
- Analysis of research identifying opioid ligands and receptors in various human cancers.
- Synthesis of data on opioid peptide mechanisms and tumor growth regulation.
Main Results:
- Opioid ligands and receptors are widely identified across diverse primary human tumors and cancer cell lines.
- Endogenous opioid systems play a significant role in the growth of both normal and abnormal tissues.
- Evidence suggests opioids are involved in the regulation of tumor progression and development.
Conclusions:
- Opioid systems represent a critical area of study in oncology.
- Understanding opioid involvement in cancer could lead to novel therapeutic strategies.
- Further research into opioid peptide mechanisms in carcinoma is warranted.